COVID-19 Home Test Our over-the-counter, rapid self-test detects SARS-CoV-2 antigen with results in 15 minutes. The test is suitable for ages 2+ years for symptomatic and asymptomatic use.
Responding to the COVID-19 global pandemic
Ellume is developing next generation diagnostic products to address the current COVID-19 healthcare burden on our global community.
US$30M award for COVID-19 diagnostics
US National Institutes of Health (NIH) has awarded Ellume US$30million to accelerate the company’s range of COVID-19 antigen tests.
Global partnership with QIAGEN for COVID-19 diagnosis
Ellume has partnered with global diagnostics company QIAGEN to bring fast, reliable COVID tests to market, addressing the global demand for rapid diagnostic tests.
We develop, manufacture, and commercialize the next generation of digitally enabled diagnostic products for healthcare professionals and consumers.